GSK invests Rs 203 mn in ayurvedic manufacturing facility
Embarking on yet another milestone, GlaxoSmithKline Consumer
Healthcare – Sri Lanka, (GSK) launched the new local manufacturing
facility for Eno (Ayurvedic powder for acidity) and Iodex (Ayurvedic
Balm) with an investment of Rs 203 million , re-affirming its commitment
to the Sri Lankan economy.
|
Basil Rajapaksa, Minister of Economic Development
commissioning the new manufacturing facility |
This comes following the commission of GSK’s manufacturing facility
for Panadol tablets in April 2012, with an investment of Rs 217 million.
The new Eno and Iodex manufacturing facility is amongst the largest
state of the art ayurvedha production facilities in Sri Lanka and
conforms to GSK’s strictest global quality standards; a testament to
GSK’s promise to its community to help people do more, feel better and
live longer.”
The new facilities will be located adjacent to its present
pharmaceutical operation in Moratuwa and will have over 65 employees,
making a contribution to the area’s employment scenario. The new
facility was declared open by Basil Rajapaksa, Minister for Economic
Development in the presence of many dignitaries and GSK personnel.
Commenting at the launch ceremony, Managing Director of GSK Consumer
Healthcare Sri Lanka, T.S Dayanand, said “At a time when Sri Lanka is
poised for growth in all economic sectors, GSK is proud to unveil
another initiative to support ‘Nation Building’ by commissioning the Eno
and Iodex plants.
“ We strongly believe that this investment will further strengthen
the ayurvedic manufacturing landscape in Sri Lanka. GSK employs over 500
people and works closely with over 200 business partners in Sri Lanka,
thereby touching lives of numerous people.
We will continue to live up to our vision of improving the quality of
human life by enabling people to do more, feel better and live longer.”
GlaxoSmithKline Consumer Healthcare – Sri Lanka is part of
GlaxoSmithKline PLC. – one of the world’s leading research-based
pharmaceutical and healthcare companies operating in 117 countries that
is committed to improving the quality of human life by enabling people
to do more, feel better and live longer. |
